Joanna Pucilowska, MS, PhD

Joanna Pucilowska MS, PhD

Director, Immune Monitoring and Cancer Omics Services

Scientific Partnerships and Business Development, Oncology

Biographical Sketch

Dr. Pucilowska received her M.S. in Human Genetics from SUNY New Paltz, NY and her Ph.D. from Case Western Reserve University, OH. In her graduate and postdoctoral work she studied the role of MAPK signaling in brain development and autism. She focused on ERK kinases or mutations in their upstream regulators which result in neuro-cardio- facial-cutaneous syndromes and are associated with developmental abnormalities, cognitive deficits, and autism.

Seeking more translational approach, she pivoted her career to focus her work on clinical research analytics and novel cancer treatments. Working with clinicians, pathologists, bench and computational scientists she applied her expertise in multi-modal and multidisciplinary disease like autism, to develop an integrated, efficient, clinically relevant data and research analytics flow.

She joined the Knight Cancer Center in January 2020 where she has developed an Immune Monitoring and Cancer Omics Services which aims to support clinical research programs, clinical trials and academic and industry partnerships with state-of-the art technology backed by meaningful and deep analytics. She thrives in fast paced, problem solving and open-minded environment, where everyone contributes to hypothesis driven, highly actionable and meaningful data in support of novel drug discovery and best patient care.

 

Innovations in Testing
View All Tests

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More